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Abstract
Background: Parkinson’s disease is characterized by the presence of cytoplasmic inclusions, known as Lewy bodies,
containing both aggregated a-synuclein and its interaction partner, synphilin-1. While synphilin-1 is known to accelerate
inclusion formation by a-synuclein in mammalian cells, its effect on cytotoxicity remains elusive.
Methodology/Principal Findings: We expressed wild-type synphilin-1 or its R621C mutant either alone or in combination
with a-synuclein in the yeast Saccharomyces cerevisiae and monitored the intracellular localization and inclusion formation
of the proteins as well as the repercussions on growth, oxidative stress and cell death. We found that wild-type and mutant
synphilin-1 formed inclusions and accelerated inclusion formation by a-synuclein in yeast cells, the latter being correlated to
enhanced phosphorylation of serine-129. Synphilin-1 inclusions co-localized with lipid droplets and endomembranes.
Consistently, we found that wild-type and mutant synphilin-1 interacts with detergent-resistant membrane domains, known
as lipid rafts. The expression of synphilin-1 did not incite a marked growth defect in exponential cultures, which is likely due
to the formation of aggresomes and the retrograde transport of inclusions from the daughter cells back to the mother cells.
However, when the cultures approached stationary phase and during subsequent ageing of the yeast cells, both wild-type
and mutant synphilin-1 reduced survival and triggered apoptotic and necrotic cell death, albeit to a different extent. Most
interestingly, synphilin-1 did not trigger cytotoxicity in ageing cells lacking the sirtuin Sir2. This indicates that the expression
of synphilin-1 in wild-type cells causes the deregulation of Sir2-dependent processes, such as the maintenance of the
autophagic flux in response to nutrient starvation.
Conclusions/Significance: Our findings demonstrate that wild-type and mutant synphilin-1 are lipid raft interacting
proteins that form inclusions and accelerate inclusion formation of a-synuclein when expressed in yeast. Synphilin-1 thereby
induces cytotoxicity, an effect most pronounced for the wild-type protein and mediated via Sir2-dependent processes.
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Introduction
Parkinson’s disease (PD) is the most common neurodegenerative
movement disorder affecting about 2% of the population over the
age of 65 years. Typical symptoms of PD include muscle rigidity,
bradykinesia, postural instability and resting tremors. The
neuropathological hallmarks of the disease consist of a progressive
degeneration of dopaminergic neurons of the substantia nigra pars
compacta and the presence of eosinophilic cytoplasmic inclusions
called Lewy bodies (LB). In addition to a-synuclein (a-Syn), which
is the major component, many other proteins have been detected
in LB, including the a-Syn-interacting protein synphilin-1 [1,2,3].
a-Syn is a small presynaptic protein of 140 amino acids. Its
cellular function is still unknown but a regulatory role in dopamine
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suggested [3]. Recently, it was proposed that a-Syn is involved
in vesicular priming and vesicular membrane fusion [4], possibly
by ameliorating complex formation of the plasma membrane and
vesicular SNARE proteins [5]. In addition, a-Syn has been
reported to perform a chaperone-like activity [5,6,7,8]. a-Syn has
the propensity to self-assemble and to form oligomeric protofibrils,
which can further mature into different types of fibers and
aggregates. Though the exact mechanism that initiates oligomer-
ization and aggregation is still elusive, several studies indicated that
the process is dependent on the central hydrophobic domain of a-
Syn and initiated by membrane binding through its N-terminal
repeat region [1,9,10]. In addition, oxidative stress [11] as well as
modifications of a-Syn, such as tyrosine nitration [12], phosphor-
ylation [13] or C-terminal truncation [14], have been implicated
in the process of oligomerization and aggregation.
Synphilin-1 is another presynaptic protein that was first
identified by a yeast two-hybrid screen aiming to recover proteins
that associate with a-Syn [15]. The physiological function of
synphilin-1 is unknown but since the protein binds synaptic
vesicles, it was proposed that synphilin-1 exerts a synaptic function
in concert with a-Syn [16]. More recent studies suggested that
synphilin-1 could act as a modulator of the ubiquitin-proteasome
system [17,18]. Overexpression of synphilin-1 in cell cultures was
shown to promote inclusion formation by a-Syn under conditions
of proteasome inhibition [19,20]. Three studies reported that these
inclusions represent aggresomes that can be cleared from the cell
by autophagy and therefore should be considered as cytoprotective
[21,22,23]. Interestingly, the capacity of synphilin-1 to form such
inclusions apparently decreased upon the introduction of the
R621C substitution, a mutation initially identified in German PD
patients but later also found in healthy individuals [24,25].
Moreover, cells that express this R621C mutant appear more
susceptible to staurosporine-induced apoptosis [24]. Recent studies
examined the repercussions of synphilin-1 when expressed in mice
brains, but the phenotypes reported by different groups are
inconsistent. One group showed that synphilin-1 was polyubiqui-
tinated and partially insoluble but found no signs of neurodegen-
eration [26], while another group demonstrated that the presence
of ubiquitin-positive inclusions coincided with cell loss in the
cerebellum [27]. The overexpression of synphilin-1 in mouse brain
by means of adenoviral vectors was reported to induce inclusion
formation and cell death of dopaminergic neurons [28]. Most
recently, a double transgenic model was generated combining
expression of synphilin-1 and the A53T a-Syn mutant and in this
case synphilin-1 was found to attenuate a-Syn-induced neuronal
decline [23]. Thus, the influence of synphilin-1 expression on cell
viability is presently not clear.
The identification of synphilin-1 as interaction partner of a-Syn
through a yeast two-hybrid screening implicates that the con-
ditions enabling such an interaction are preserved in this lower
eukaryote. In addition, several studies validated the use of yeast as
a powerful model to gain further insights and uncover new clues
underlying the pathophysiology of proteins associated with
neurodegeneration, including a-Syn [29,30,31,32,33]. These
studies were not only instrumental to decipher structural pro-
perties of a-Syn associated with inclusion formation [9,10] but
they also allowed to confine a-Syn-mediated toxicity to
the impairment of protein quality control systems and defects
in ER-to-Golgi vesicular transport as well as endocytosis
[31,32,34,35,36]. Additionally, transgenic yeast models helped to
uncover the crucial role of oxidative stress and mitochondrial
(dys)function in the execution of apoptotic and necrotic cell death
induced by a-Syn [37,38]. In this study, we expressed wild-type or
mutant synphilin-1 in yeast and compared their capacity to form
inclusions and to contribute to cellular stress and cell death in the
absence or presence of a-Syn.
Results
Wild-type synphilin-1 enhances the a-Syn-induced
growth defect in yeast
At present, it is not clear whether synphilin-1 triggers
cytotoxicity by itself or solely acts as an accelerator that boosts
the cellular stress responses induced by its interaction partner a-
Syn. To address this question in more detail, we constitutively
expressed wild-type synphilin-1 (SY
WT), the R621C mutant
(SY
R621C) and a-Syn in S. cerevisiae, either alone or in combination,
and monitored the effects on growth. The expression was
confirmed by Western blot analysis and immunodetection. The
proteins SY
WT and SY
R621C were expressed at similar levels and
produced besides a 130 kDa full length protein additional
products of 80 kDa, 60 kDa and 40 kDa (Fig. 1A). In addition,
SY
WT produced a faint 90 kDa band, which was not observed for
SY
R621C. This is consistent with observations previously made
upon overexpression of wild-type and mutant synphilin-1 in
HEK293 and SH-SY5Y cells [24] as well as in brain tissue from
human and transgenic mice [27,39]. Hence, our data suggest that
synphilin-1 is being processed in a similar way in yeast and
mammalian cells. As judged from the relative intensities obtained
for 80 kDa and 40 kDa products in extracts from cells solely
expressing synphilin-1, the efficiency of processing appeared to be
different for the wild-type and the mutant protein. However, this
difference was less obvious in extracts of cells expressing these
proteins in combination with a-Syn. This probably relates to the
impairment of protein quality control and clearance mechanisms
known to occur upon expression of a-Syn (see [32] and references
therein).
Growth analysis demonstrated that the expression of SY
R621C in
yeast exerted only moderate effects, both when expressed alone or
together with a-Syn (Fig. 1B). In contrast, expression of SY
WT
produced a more pronounced growth phenotype and further
aggravated the strong phenotype that we and others previously
reported to occur upon expression of a-Syn [30,31,40]. To further
confirm that these growth defects were not simply due to an
overload of the protein expression machinery, we also performed a
growth experiment with cells expressing LacZ. As expected, the
expression of LacZ did neither produce a growth phenotype, nor
did it aggravate the a-Syn-induced growth defect (data not shown).
Wild-type and mutant synhilin-1 increase the inclusion
formation of a-Syn in yeast
Next, we examined whether the growth properties of the strains
expressing SY
WT or SY
R621C could relate to the capacity of the
proteins to form inclusions and to enhance inclusion formation by
a-Syn, as previously shown in other cellular and transgenic models
[3,15,20,22,23,24]. To this end, we expressed a-Syn as C-
terminally tagged EGFP fusion and synphilin-1 as N-terminally
tagged dsRed fusion and examined the cells in early exponential
phase. In line with other studies [30,31,40,41], a-Syn-EGFP
localized at the plasma membrane where it started to form
inclusions in approximately 2% of the cells (Fig. 2A,E). Both
dsRed-SY
WT and dsRed-SY
R621C displayed a dispersed cytoplas-
mic distribution in the majority of the yeast cells. However, the
proteins concentrated in distinct foci in about one third of the cells
expressing dsRed-SY
WT and in one fifth of the cells expressing
dsRed-SY
R621C (Fig. 2A,D). Similar as for a-Syn, these foci
appeared to be formed close to the cell periphery in exponential
Synphilin-1 Yeast Model
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inclusions when the cells approached the diauxic shift to enter
stationary phase. The difference in the capacity of dsRed-SY
WT
and dsRed-SY
R621C to form foci and inclusions cannot be ascribed
to differences in expression, since similar levels were detected upon
western blot analysis (Fig. 2C). Hence, our data therefore suggest
that the R621C mutation decreases the capacity of the protein to
form inclusions, which is consistent with data obtained in SH-
SY5Y cells [24]. As described below, inclusions were also evident
with similar percentages when SY
WT was expressed as EGFP
fusion, confirming that inclusion formation is a property associated
to synphilin-1 itself and not artificially produced by the fluorescent
tag.
Analysis of the strains co-expressing tagged a-Syn and
synphilin-1 versions revealed that most of the cells were still
inclusion-negative and displayed a-Syn-EGFP at the plasma
membrane and synphilin-1 dispersed throughout the cytoplasm.
Those cells that formed inclusions fell into three categories
(Fig. 2B), with the largest group being the cells harboring
synphilin-1 inclusions but no visible a-Syn inclusions. Some of
the cells presented inclusions for both proteins, which in many, but
not all of the cases, consisted of inclusions where a-Syn-EGFP
clearly co-localized with dsRed-SY
WT or dsRed-SY
R621C.I na
minor fraction of the cells, a-Syn inclusions were detectable
without apparent synphilin-1 inclusions. When quantified, it
became clear that a-Syn had only a minor impact on inclusion
formation of synphilin-1, as the amount of cells with dsRed-SY
WT
or dsRed-SY
R621C inclusions did not change dramatically
(Fig. 2D). Conversely, however, the presence of wild-type or
mutant synphilin-1 clearly accelerated inclusion formation by a-
Syn. Indeed, the number of cells with a-Syn-EGFP inclusions
increased from 2%, in case of expression of a-Syn alone, to 13% in
case of combined expression with SY
WT and 10% when co-
expressed with SY
R621C (Fig. 2E). These data favor an unilateral
interaction between the proteins in that a-Syn cannot seed
inclusion formation by synphilin-1, while synphilin-1 can still
recruit a-Syn and thereby propagate nucleation of the latter.
Moreover, the data obviously indicate that the level of inclusions
formed by these proteins does not correlate with the severity of
their associated growth defects when expressed in yeast.
Synphilin-1 is a lipid raft binding protein
Synphilin-1 was shown to bind synaptic vesicles [16] and is
known to bind phospholipids, membranes and lipid droplets
[39,42]. Since the membrane-binding properties of a-Syn are
thought to be relevant for its pathologic activity [1,9,10], we
speculated that also for synphilin-1 the binding to different types of
lipid structures could be linked to its inclusion formation. To
elaborate on this, we incubated exponential cells expressing
dsRed-SY
WT with the green fluorescent probe C1-BODIPY 500/
510-C12, a fatty acid that serves as precursor for the biosynthesis
of phospholipids. After one hour incubation, the probe stained
distinct small foci, which likely represent sites of newly formed
endomembranes. As shown in the overlay, most of these foci co-
localized with the inclusions formed by dsRed-SY
WT (Fig. 3A,
upper panel). Next, we stained cells for lipid droplets with the non-
polar green fluorescent probe BODIPY 505/515. Again, co-
localization with inclusions formed by dsRed-SY
WT could be
detected, though we observed that cells contained more inclusions
than lipid droplets (Fig. 3A, middle panel). Combined, these data
confirm that synphilin-1 is a lipid binding protein and suggest that
lipid binding is required for inclusion formation. Finally, to assess
whether the inclusion formation of synphilin-1 could involve an
interaction with so-called detergent resistant membrane domains
(DRMs), also known as lipid rafts, we performed a staining with
filipin, a dye specific for sterols [43]. As shown, many of the
inclusions formed by dsRed-SY
WT in exponential cells localized at
sites enriched for sterols (Fig. 3A, lower panel).
Figure 1. Synphilin-1 and a-Syn toxicity in exponentially
growing yeast cells. A: Western blot analysis of control strains
transformed with empty plasmids (Ctrl.) or strains expressing SY
WT or
SY
R621C without or with co-expression of a-Syn. The open arrowhead
indicates the presence of a 90 kDa proteolytic fragment in case of SY
WT
expression. Immunodetection was performed using primary antibodies
directed against synphilin-1, a-Syn or Adh2 as indicated on the left.
Molecular weight markers are indicated on the right. B: Growth curves
of the BY4741 wild-type strains transformed with an empty plasmid (%)
or constructs allowing for expression of a-Syn (&), SY
WT (D), SY
R621C
(m),a-Syn and SY
WT (#)o ra-Syn and SY
R621C (N). The data represent
the mean of at least three independent transformants.
doi:10.1371/journal.pone.0013700.g001
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we performed fractionations and separated the insoluble mem-
branes by flotation on an Optiprep gradient. For comparison, we
included a-Syn-EGFP in this analysis as we previously found that
only a minor fraction of native a-Syn and its fusion protein could
interact with DRMs [31]. We expected a better interaction of
synphilin-1 with DRMs given its higher propensity to form
inclusions. Indeed, SY
WT was almost entirely recovered in those
fractions containing the yeast DRM marker Pma1 (Fig. 3B, upper
panel). These fractions not only contained the monomeric 130
kDa form but also a higher-order complex of just more than 250
kDa, which most likely corresponds to a dimeric form. In fact, a
very recent study confirmed that synphilin-1 forms antiparallel
dimers through its central coiled-coil domain [20]. In contrast to
synphilin-1, the fusion protein a-Syn-EGFP was mainly recovered
in the fractions containing detergent soluble material (Fig. 3B,
lower panel), thereby confirming our previously reported obser-
vations. We also investigated whether synphilin-1 and a-Syn
mutually affected each other’s DRM-binding properties. Although
we noticed somewhat reduced dimerization of SY
WT,n o
significant changes were observable for lipid raft binding of the
monomeric forms upon combined expression. We also did not
observe significant changes for the lipid raft binding of a-Syn-
EGFP upon co-expression of synphilin-1, but rather a general
decrease in a-Syn content in all fractions. Analysis of SY
R621C
confirmed that this mutant displays altered lipid binding affinities
since higher concentrations of the monomeric form were present
in the more detergent-soluble fractions. However, the dimeric
Figure 2. Synphilin-1 induces inclusion formation of a-Syn in yeast. A: Fluorescence microscopic visualization and intracellular localization of
the a-Syn–EGFP (upper panels), dsRed-SY
WT (middle panels) or dsRed-SY
R621C (lower panels) fusion proteins expressed separately in the BY4741 wild-
type yeast strain. The panels display cells without (left) or with (right) aggregates. The percentages refer to the number of cells with or without
inclusions in an exponential culture. Cells expressing native EGFP or dsRed served as controls and showed a dispersed cytoplasmic localization. B:
Fluorescence microscopic visualization and intracellular localization of a-Syn–EGFP and dsRed-SY
WT upon combined expression in the BY4741 wild-
type yeast strain. The upper panels display cells where both fusion proteins co-localize, the middle panels cells with intracellular inclusions of
synphilin-1 and plasma membrane localized a-Syn, and the lower panels cells with peripheral inclusions of a-Syn and a dispersed cytoplasmic
distribution of synphilin-1. C: Western blot analysis of strains transformed with an empty plasmid (Ctrl.) or a construct allowing the expression of
dsRed-SY
WT or dsRed-SY
R621C. Immunodetection was performed using primary antibodies directed against synphilin-1 or Adh2 as indicated on the
left. Molecular weight markers are indicated on the right. D and E: The percentage of cells containing inclusions of wild-type or mutant synphilin-1 (D)
or a-Syn (E) in exponential cultures. Data represent the combined results of at least three independent experiments. Error bars represent the variation
between different counts. Significance was assayed on the total amount of cells counted using a t-test (***=p,0.001).
doi:10.1371/journal.pone.0013700.g002
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fractions, suggesting that binding to lipid rafts and dimerization
could be associated.
In yeast, lipid rafts are enriched in sphingolipids and ergosterol,
the yeast counterpart of mammalian cholesterol. To obtain
additional confirmation that synphilin-1 is a true lipid raft binding
protein, we expressed SY
WT in the strain lacking Erg24. ERG24
encodes the sterol C-14 reductase, which is required for proper
ergosterol biosynthesis [44]. Fractionation of membranes of the
erg24D mutant demonstrated that the monomeric form of SY
WT
was displaced to the more dense fractions containing detergent-
soluble material, indicative that synphilin-1 is, indeed a bona fide
lipid raft binding protein (Fig. 3C). Also in this case, most dimers
of SY
WT were still recovered in the DRM fractions ruling out the
possibility that dimerization would simply be an artifact of
concentrating the monomeric protein in the DRM fractions.
To our knowledge, this is the first report of synphilin-1 being a
lipid raft binding protein. Therefore, we wondered if the DRM
localization of synphilin-1 could be extended to mammalian cells
and evaluated the presence of endogenous synphilin-1 in lipid rafts
of primary neuronal cultures from the mouse cortex based on co-
localization with the cholera toxin B subunit [45]. Confocal
fluorescence microcopy confirmed significant co-localization of
synphilin-1 and cholera toxin B, both in the neurites (Fig. 4A, left
panels) as well as the neuronal cell body (Fig. 4A, right panels).
Next, we analyzed the interaction of synphilin-1 with DRMs by
means of membrane fractionations. Consistent with previously
reported data [16], endogenous synphilin-1 was expressed as a 90
kDa protein in this cellular system and as shown, a substantial
amount of the protein was recovered in the same fractions as the
mammalian DRM marker flotillin-1 (Fig. 4B). Hence, synphilin-1
is also a lipid raft binding protein in neuronal cells. Note that there
is no evidence that mouse synphilin-1 readily forms inclusions in
neurons [23,27] and perhaps this may explain why we only
detected the monomeric form and no dimers. To conclude this
analysis, we performed immunodetection for endogenous mice a-
Syn and found this protein to be mainly distributed over the
fractions containing detergent-soluble material, thereby confirm-
ing the data obtained in yeast.
Co-expression of synphilin-1 increases S129-
phosphorylation of a-Syn
Several studies in brain and transgenic models indicated that a-
Syn phosphorylation at serine-129 (S129) is an early event in the
pathology of Parkinson’s disease [13,46,47,48]. Also in yeast,
recent studies confirmed a good correlation between the
phosphorylation of a-Syn at S129 and a-Syn-mediated cytotox-
Figure 3. Synphilin-1 interaction with lipid rafts in yeast membranes. A: Co-localization of inclusions formed by dsRed-SY
WT with lipid
particles and endomembranes (Bodipy 500/510; upper panels), lipid droplets (Bodipy 505/515; middle panels), or sterol-enriched membrane domains
(Filipin; lower panels) in yeast. B and C: Interaction with lipid rafts of SY
WT,S Y
R621C or a-Syn–EGFP in yeast membranes of the wild-type BY4741 strain
(B) or its isogenic erg24D mutant (C). The proteins expressed are indicated on the right, the antibodies used for immunodetection on the left. Lipid
raft fractions (boxed areas) were identified using the yeast lipid raft marker Pma1. The open arrowhead indicates the position of the 250 kDa
molecular weight marker, the black arrowhead that of the 150 kDa marker.
doi:10.1371/journal.pone.0013700.g003
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be increased under conditions where its inclusion formation
capacity and cytotoxicity is enhanced by co-expression with
synphilin-1. Using a phospho-specific antibody against S129, we
compared the immunoreactivity of lysates from cells expressing a-
Syn either alone or in combination with SY
WT or SY
R621C.
Phosphorylation of a-Syn on S129 was indeed increased both in
the presence of wild-type and mutant synphilin-1 (Fig. 5A), but
only in case of the former it was significant.
To extend our observation to a mammalian system, we
monitored the formation of inclusions and S129-phosphorylation
of a-Syn-EGFP when expressed either alone or in combination
with SY
WT in H4 neuroglioma cells. In line with data obtained
with other cell lines [15,20], only a small number of cells presented
inclusions when the fusion protein was overexpressed alone, but
this number increased almost eight times upon co-expression with
synphilin-1 (Fig. 5B). Similar as in yeast, the enhanced formation
of a-Syn-inclusions was paralleled by an increase in S129-
phosphorylation (Fig. 5C).
Synphilin-1 confers toxicity in aged yeast cells
Though many neurodegenerative disorders are tightly associat-
ed with ageing, the relationship between synphilin-1-mediated
toxicity, ageing and cell death has not been studied in detail.
Recently, we performed yeast chronological ageing experiments, a
well established model to study oxidative damage and ageing in
post-mitotic cells [49,50], and demonstrated that a-Syn-mediated
toxicity correlated with enhanced levels of reactive oxygen species
(ROS) produced in the respiratory chain in mitochondria and, as
such, with signs of apoptotic and necrotic cell death [32,37]. As
synphilin-1 was shown to render SH-SY5Y cells more sensitive to
apoptosis [24], we set out to compare the respective contributions
of a-Syn and synphilin-1 to cell death in yeast.
First, we analyzed the effect of a-Syn, SY
WT or SY
R621C
expression on the ROS production at different time points after the
inoculation of the cells on fermentative glucose-containing
medium. Quantification of ROS production was analyzed by the
conversion of non-fluorescent DHE into fluorescent ethidium, a
reaction catalyzed by superoxides. As shown, expression of SY
WT
alone or in combination with a-Syn triggered a significant and
equivalent increase in the number of DHE positive cells as
compared to the control. Such a marked increase was not observed
with the strain expressing only SY
R621C, mainly because this strain,
as well as the control strain, produced less ROS once they traversed
the diauxic shift and switched to respiratory growth (Fig. 6A). This
growth phase, was only reached by the other strains approximately
12 hours later (see Fig. 1B). To monitor the effect of synphilin-1
and a-Syn expression on cell death and cell survival, we therefore
analyzed in more detail a sample taken 36 h after inoculation. As
expected, the levels of ROS producing cells correlated nicely with
the number of cells displaying signs of apoptotic and necrotic cell
death as measured by annexinV and propidium iodide staining,
respectively(Fig.6B,D). The totalnumberof dying cellswasequally
high for the strains expressing SY
WT or a-Syn and lower for strains
expressing SY
R621C, again indicating that the R621C mutation
reduced synphilin-1 cytotoxicity. The latter became even more
significant when counting the number of surviving cells by means of
colony formation. In fact, here we noticed that mutant synphilin-1
somehow protected cells from a-Syn-instigated toxicity as we
observed an increase in surviving cells of 16% upon combined
expression of a-Syn and SY
R621C (Fig. 6C). Such a protective role
was not observed for the wild-type protein since the percentages of
viable cells were equally low for strains expressing a-Syn with or
without co-expression of SY
WT.
Figure 4. Synphilin-1 interaction with lipid rafts in membranes
of mouse primary neurons. A: Pictures obtained by confocal
microscopy to determine co-localization of inclusions formed by
mouse synphilin-1 with lipid rafts in membranes of mouse primary
neuronal cultures. Shown are representative pictures taken at the
plane of the neurites (left panels) or of the neuronal cell body (right
panels). Synphilin-1 was detected using a goat anti-synphilin 1 as
primary antibody and donkey anti-goat IgG (H+L) coupled to Alexa
Fluor 568 as secondary antibody. The cholera toxin subunit B served as
a marker for lipid rafts. DAPI was used to stain nuclei. The white bar in
the upper panel corresponds to a size of 10 mm. B: Interaction with
lipid rafts of endogenous SY
WT and a-Syn in membranes of mouse
primary neuronal cultures. Lipid raft fractions (boxed areas) were
identified using the mammalian lipid raft marker flotillin-1. The open
arrowhead indicates the position of the 100 kDa molecular weight
marker.
doi:10.1371/journal.pone.0013700.g004
Synphilin-1 Yeast Model
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WT and a-Syn induced cell death to a
similar extent in cultures approaching stationary phase was rather
surprising as it contrasted with the observations made during
exponential growth where a-Syn had a more pronounced impact
(Fig. 1B). It suggested that the expression of synphilin-1 conferred
toxicity mainly when cells were ceasing division, while the
expression of a-Syn imposed restrictions at different stages during
growth. To investigate this in more detail, we performed a
chronological ageing experiment and monitored cell survival
(Fig. 6E) and ROS formation (Fig. 6F) when the cultures were kept
for a period of two weeks. This confirmed that SY
WT and a-Syn
equally reduced the chronological life span of aged yeast cells and,
interestingly, this effect appeared to be synergistic when the
expression of both proteins was combined. As expected, the
SY
R621C mutant hardly affected chronological life span by itself,
but when its expression was combined with a-Syn, we noticed that
with time also this mutant protein triggered a synergistic effect as
evidenced by enhanced production of ROS and decreased cell
Figure 5. Co-expression of synphilin-1 increases a-Syn S129-phosphorylation. A: Phosphorylation of a-Syn at S129 in the BY4741 wild-type
strain when the expression of a-Syn was combined with an empty plasmid or constructs allowing for co-expression of SY
WT or SY
R621C as indicated.
The panel on the left represents the average S129-phosphorylation as determined by immunodetection using a P-S129 specific monoclonal antibody,
shown in the right panel, and quantified relative to intensity obtained for immunodetection with a polyclonal a-Syn antibody. B: The left panel shows
the average number of H4 neuroglioma cells containing inclusions formed by a-Syn–EGFP when expressed alone or in combination with SY
WT as
determined by fluorescence microscopic visualization, for which a representative picture is shown in the right panel. C: Phosphorylation of a-Syn at
S129 in H4 neuroglioma cells as detected by immunodetection using a P-S129 specific monoclonal antibody and quantified relative to the intensity
obtained for immunodetection with a polyclonal a-Syn antibody. The panel on the left represents the relative average phosphorylation, the panel on
the right a corresponding Western blot analysis. All data represent the mean 6 SEM of at least three independent experiments. Significance was
assayed using a 1-way ANOVA (A) or t-test (B and C)(*=p,0.05; **=p,0.01; ***=p,0.001).
doi:10.1371/journal.pone.0013700.g005
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However, consistent with the data described above, mutant
synphilin-1 somehow maintained its protective properties through-
out the ageing experiment. Indeed, while the strain that expressed
both SY
WT and a-Syn showed a continuous decline in cell
viability, the strain with combined expression of SY
R621C and a-
Syn maintained cell viability from the fourth day onward. Hence,
this resulted in a progressive increasing difference in the
percentage of surviving cells between both strains (p,0.05 at
day 6; p,0.01 at day 11;p,0.001 at day 14).
In all experiments described above, we again used cells that
expressed LacZ without or with co-expression of a-Syn as
additional control. As expected, the expression of LacZ did not
trigger toxicity or changes in cell death related phenotypes (data
not shown).
The sirtuin Sir2 mediates synphilin-1 toxicity
Several age-related phenomena in higher and lower eukaryotes
are modulated by the activities of sirtuins or silent information
regulators. The yeast sirtuin Sir2 was shown to play both pro- and
anti-ageing roles. On the one hand, enhanced Sir2 activity extends
replicative longevity or the number of buddings of a mother cell
[51], while on the other hand, the protein seems to act as inhibitor
of chronological ageing and the ability of yeast cells to maintain
their viability in stationary phase [52]. In higher eukaryotes, most
studies focussed on the role of SIRT1 as mediator to extend
longevity by calorie restriction and on the potential benefits of this
protein to prevent neuronal loss [53]. Recent studies, however,
reported that inhibition of another member of the sirtuin family,
i.e. SIRT2, rescued H4 neuroglioma cells from a-Syn-induced
cytotoxicity and prevented dopaminergic cell death in a Drosophila
model [54,55]. This observation led us to investigate the possible
involvement of Sir2 in mediating synphilin-1 toxicity in our yeast
model. First, we analyzed the effect of SIR2 deletion on the
survival of cells expressing SY
WT with or without co-expression of
a-Syn. Consistent with the observations made in mammalian cells
and Drosophila, the level of SY
WT-induced toxicity was significantly
lower in the strain lacking Sir2 as compared to the wild-type strain
(Fig. 7A). Also a-Syn instigated a lower toxicity in the sir2D
deletion mutant in comparison to the wild-type strain, a difference
that became significant once the cells entered stationary phase.
Next, we performed a chronological ageing experiment on an
independent set of transformants, which carried either a single
control plasmid or a plasmid allowing for SY
WT expression. As
compared to the double transformed cells described above, the
synphilin-1-induced toxicity levels were lower in these single
transformants. Nevertheless, the difference in survival and ROS
production between wild-type cells with or without SY
WT
expression was still highly significant throughout the course of
the experiment (Fig. 7B,C). For the sir2D strain harboring the
control plasmid, we noticed inherent lower survival rates and
higher levels of ROS during the ageing experiment. Most
interestingly, we could not observe any additional toxic effect
induced by synphilin-1 in this mutant strain. Indeed, with the sir2D
strain the curves depicting the number of viable cells or DHE-
positive cells, with or without expression of SY
WT, almost
completely overlapped. Hence, it can be concluded that Sir2
plays an essential role in mediating synphilin-1 toxicity.
Aggresome formation and mitotic partitioning of
synphilin-1 inclusions
Recent studies in mammalian cells and transgenic mice
suggested that upon failure of the proteasome, cells start to
accumulate synphilin-1 in aggresomes, which are believed to be
cytoprotective since they can be cleared from the cell by
autophagy [21,22,23]. Aggresomes are formed by convergence
of smaller inclusions at the centrosomes via microtubule-based
transport. In yeast, the aggresome co-localizes with the spindle
pole body [56], the prototype of the centrosome located in the
nuclear envelope [57]. As mentioned above, we observed that
when the cultures approached the diauxic shift to enter stationary
phase many cells displayed one to two large synphilin-1 inclusions.
These cells were often also larger in size. To determine whether
these inclusions could correspond to aggresomes, we first
performed a nuclear staining with DAPI on wild-type and sir2D
cells expressing dsRed-SY
WT after 36 h of growth. This revealed
that the large inclusion, or one of the inclusions when there were
more, was in close proximity of the nucleus in the majority of wild-
type and sir2D cells (Fig. 8A). Also in the strains that combined
expression of dsRed-SY
WT and a-Syn this appeared to be the case
(data not shown). Next, we tested whether the large inclusions
were cytoprotective. To this end, we transformed the wild-type
and sir2D strains with a construct allowing expression of a N-
terminally tagged EGFP-SY
WT fusion. This fusion protein
triggered comparable growth effects as native SY
WT or dsRed-
SY
WT (data not shown). Similar as above, the strains were grown
for 36h and cells were then stained with DHE and propidium
iodide to determine ROS production and viability, respectively. As
shown, both dyes stained cells with a dispersed cytoplasmic
distribution of synphilin-1 or, occasionally, with small inclusions.
In contrast, cells with larger inclusions almost completely failed to
stain positive for DHE or propidium iodide (Fig. 8C,D). Again,
similar observations were made with the strains combining
expression of EGFP-SY
WT and a-Syn (data not shown). Taken
together, these data favor that the large inclusions formed by
SY
WT correspond to cytoprotective aggresomes.
Aggresome formation and subsequent autophagic clearance
may account for the observation that, despite its higher propensity
to aggregate, synphilin-1 remains less toxic than a-Syn in
exponential growing yeast cells. Moreover, several studies in
higher eukaryotic systems documented the essential role of sirtuins
for maintenance of autophagy during conditions of nutrient
starvation [58,59]. This role of the sirtuins is most likely conserved
also for yeast Sir2 [60] and, as such, it may provide a first clue for
the difference in synphilin-1 instigated toxicity between ageing
wild-type cells and ageing sir2D cells. Most recently, Sir2 was
shown to be required for the proper CCT-chaperonin-dependent
folding of actin and the establishment of cell polarity [61]. The
Figure 6. a-Syn and synphilin-1 equally enhance cell death in aged yeast cells. A: Quantification of ROS accumulation using DHE staining at
different times during growth of yeast strains transformed with an empty plasmid (%, Ctrl.) or constructs allowing for expression of a-Syn (&), SY
WT
(D), SY
R621C (m),a-Syn and SY
WT (#)o ra-Syn and SY
R621C (N). B: Quantification of the number of cells that display phosphatidylserine externalization
or loss of membrane integrity using annexinV/propidium iodide (PI) co-staining at 36 h of growth in the strains used in A. C: Quantification of viable
cells present in the strains used in A at 36 h of growth as determined by their ability to form colonies. D: Fluorescence microscopic visualization of
cells expressing combinations of a-Syn, SY
WT or SY
R621C as indicated and stained with DHE (upper panels) or co-stained with annexinV and PI (lower
panels) after 36 h of growth. E and F: Quantification of viable cells (E) and cells producing ROS (F) in the strains used in A when kept in culture for two
weeks. All data represent mean 6 SEM of six independent transformants. Significance of the data was determined by t-tests (*=p,0.05; **=p,0.01;
***=p,0.001).
doi:10.1371/journal.pone.0013700.g006
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retention of aggregates by mother cells and the clearance of
daughter cells from aggregates via polarisome-dependent retro-
grade transport along actin cables. During our analyses, we
noticed that during mitosis the emerging buds of both wild-type
and sir2D cells, indeed, inherited synphilin-1 inclusions, which
were often positioned at the distal bud tip, i.e. the site of the
polarisome (Fig. 9A). Interestingly, the inheritance of these
inclusions occurred often before completion of chromosome
segregation (see lower panels in Fig. 8A). a-Syn, on the other
hand, followed a different inheritance pattern and was almost
exclusively received by the growing daughter cells as plasma
membrane associated protein (Fig. 9A). To demonstrate that
synphilin-1 inclusions could be subject to transport along actin
cables, we stained wild-type cells expressing dsRed-SY
WT with
Alexa Fluor 488 conjugated phalloidin to visualize actin patches
and filaments as well as with Calcofluor to visualize the cell wall.
Although only a fraction of the cells harboring synphilin-1 stained
positive for actin, our analysis not only revealed that synphilin-1
inclusions localized to actin cables but it also showed that the
individual inclusions were usually flanked by an actin patch
(Fig. 9B). The latter suggests that actin is recruited on the
inclusions and thus that synphilin-1 inclusions trigger the
delocalization of the actin cytoskeleton. To illustrate that the
transport of synphilin-1 inclusions along actin cables is equally
important to prevent synphilin-1 toxicity as microtubule-mediated
transport and aggresome formation, we compared the growth of
wild-type cells with or without expression of native SY
WT or
SY
R621C when plated on media supplemented with either
Latranculin-B, a drug causing actin-depolarization [61], or
Benomyl, a drug preventing the polymerization of tubulin [56].
This experiment showed that synphilin-1 expression conferred
hypersensitivity to both drugs and, consistent to their aggregation
propensity, that for each of the drugs the effect was by far more
pronounced upon expression of the wild-type protein than upon
expression of the mutant (Fig. 9C).
Figure 7. Sir2 mediates synphilin-1 toxicity in yeast. A: Relative quantification of viable cells as determined by their ability to form colonies at
different times after inoculation of the wild-type strain or the isogenic sir2D mutant transformed with empty plasmids or constructs allowing for
expression of a-Syn or SY
WT, either alone or in combination as indicated. The number of viable cells in samples taken after 24 h of growth of the two
strains transformed with the empty plasmids was set at 100%. B and C: Quantification of viable cells (B) and cells producing ROS (C) during
chronological ageing of the wild-type strain transformed with an empty plasmid (%) or expressing SY
WT (&) and the isogenic sir2D mutant
transformed with an empty plasmid (#) or expressing SY
WT (N). All data represent mean 6 SEM of six independent transformants. Significance of the
data was determined by t-tests (*=p,0.05; **=p,0.01; ***=p,0.001).
doi:10.1371/journal.pone.0013700.g007
Synphilin-1 Yeast Model
PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13700Synphilin-1 Yeast Model
PLoS ONE | www.plosone.org 11 October 2010 | Volume 5 | Issue 10 | e13700Discussion
During the past decade, work from several groups demonstrated
the power of yeast as a model to uncover how central players in
protein folding diseases incite cellular toxicity and cell death. a-
Syn, for instance, was found to form inclusions at the yeast plasma
membrane and the peripheral ER, to hamper protein quality
control systems and to block vesicular traffic from ER to Golgi,
endocytosis and vacuolar fusion [30,31,35,40,41]. Thereby, a-Syn
triggers oxidative stress and mitochondrial dysfunction, which
eventually leads to apoptotic and necrotic cell death [37,38]. We
now show that also the a-Syn-interacting protein synphilin-1 forms
inclusions in yeast cells, which starts with the appearance of
distinct foci at endomembranes and lipid droplets. These data
extend the results previously obtained by in vitro synphilin-1 lipid
binding assays and confirm the observation of co-localization of
the protein with lipid droplets in transfected COS7 cells [42] and
membranous structures in HEK293 cells [62]. They also
corroborate the finding that synphilin-1 associates with synaptic
vesicles in neurons [16].
Intriguingly, both wild-type synphilin-1 and the R621C mutant
displayed much higher capacities for inclusion formation than a-
Syn and we believe that this directly relates to our observation that
synphilin-1 is a true lipid raft interactor in both yeast and
mammalian cells, while a-Syn associates only poorly with these
membrane domains, as previously shown [13,31]. Such a
correlation between lipid raft interaction and inclusion formation
also holds for differences observed between wild-type and mutant
synphilin-1. Indeed, consistent with data obtained in SH-SY5Y
cells [24], we counted less yeast cells with inclusions upon
expression of SY
R621C than upon expression of SY
WT and this is
nicely recapitulated in our lipid raft binding experiments where we
found that the mutant was displaced to more detergent-soluble
fractions as compared to the wild-type protein. Mechanistically,
this is explained by the fact that the R621C mutation reduces the
lipofilicity of synphilin-1, because it is in the middle of the
sequence required for phospholipid and membrane binding [42].
Furthermore, the R621C mutation is located in the second
domain with ankyrin-like repeats that is critical for synphilin-1 self-
assembly and the formation of deleterious aggregates [22]. We also
noticed that synphilin-1 interacted with lipid rafts both as
monomer and dimer, the latter being again reduced in case of
the mutant protein. This led us to speculate that the interaction
with lipid rafts could facilitate dimerization and further self-
assembly of synphilin-1, though this certainly requires more
detailed investigations. Note that synphilin-1 dimerization has
been observed previously and found to involve the antiparallel
binding of the central coiled-coil domain [20].
In close connection to membrane binding and inclusion
formation, we found that wild-type synphilin-1 instigates a higher
toxicity than the mutant protein. This is best illustrated by the
observation that the expression of SY
WT had a more severe impact
on ROS formation and viability of post-diauxic cells than the
expression of SY
R621C. In yeast, like in all other eukaryotic cells,
ROS is not only generated due to mitochondrial activity but also
as a consequence of sustained ER-stress and activation of the
unfolded protein response (UPR) [32,63]. Interestingly, ER-stress
and the UPR were shown to enhance the biosynthesis of
endomembranes as well as the formation of lipid droplets
[64,65]. Since the binding of synphilin-1 to endomembranes and
lipid droplets is associated with the formation of inclusions, it is
conceivable that, especially in case of wild-type synphilin-1 and
certainly upon co-expression with a-Syn, cells become trapped in a
vicious circle where enhanced inclusion formation triggers
elevated levels of ER-stress and ROS and vice versa. Eventually,
this must lead to an overflow of protein quality control systems and
consequently to enhanced cell death, the latter being confirmed by
our data.
The observation that expression of SY
WT is more cytotoxic than
expression of SY
R621C in yeast disagrees with the initial reports
that the R621C mutation would be specifically associated to PD
[24]. It also seems to contradict the data suggesting that
particularly the expression of the R621C mutant rendered
HEK293 cells more susceptible for staurosporine-induced cell
death [24]. However, this effect is only observed when the
HEK293 cells were treated with proteasome inhibitors and
therefore it may be due to a more pleiotropic pharmacological
effect rather than to properties associated to the mutant proteins
itself under normal physiological conditions.
Synphilin-1 was initially characterized as a-Syn interacting
protein based on a yeast two-hybrid screen [15], indicating that
both proteins maintain their interaction properties when expressed
in S. cerevisiae. Our data confirmed the co-localization of SY
WT or
SY
R621C and a-Syn in inclusions and established that both SY
WT
and SY
R621C do enhance a-Syn inclusion formation also in yeast,
similar as previously shown in mammalian cells [15,19,20]. This
stimulatory effect on inclusion formation is apparently not mutual,
because the expression of a-Syn had only a minor impact on
inclusion formation by synphilin-1. An explanation for this
observation is straightforward. Indeed, several studies established
that aggregation of a-Syn in mammalian and yeast cells requires
the interaction with membranes via its N-terminus [1,9,10], and
the same sequence was shown to be essential for the interaction
with the coiled-coil domain of synphilin-1 [20,66]. Thus, when a-
Syn binds to membranes and is engaged to form aggregation
nuclei, the sequence needed for interaction with synphilin-1 is
occupied and no longer available. Conversely, the coiled-coil
domain of synphilin-1 does not overlap with the phospholipid
binding site [42] and thus remains exposed for recruitment of a-
Syn even when synphilin-1 is bound to membranes as a dimer
[20].
The enhanced inclusion formation by a-Syn upon co-expression
of SY
WT or SY
R621C was paralleled by an increased level of its
phosphorylation at S129. As reported previously, and similarly to
what was described in mammalian cells, S129 phosphorylation of
a-Syn in yeast cells can be mediated by different casein kinases, of
which the two plasma membrane resident kinases seem to
determine a-Syn-mediated toxicity [31]. Although it is still a
matter of debate [67], numerous studies performed in cellular and
transgenic models as well as on human brain suggested that
phosphorylation at S129 is specifically associated with a-Syn
neurotoxicity and therefore represents an early marker for PD
[13,46,68,69,70,71]. We observed that only the combined
expression of a-Syn with SY
WT triggered a more severe growth
defect when yeast cells were actively dividing, while both the
combined expression of a-Syn with SY
WT or with SY
R621C
Figure 8. Synphilin-1 forms aggresomes in cells approaching stationary phase. A: Fluorescence microscopy pictures of post-diauxic wild-
type and sir2D cells with large inclusions formed by dsRed-SY
WT and stained with DAPI to visualize the nucleus. B: Fluorescence microscopy pictures
of post-diauxic wild-type and sir2D cells expressing either EGFP or EGFP-SY
WT, as indicated, and stained with DHE to visualize ROS producing cells (left
panels) or with PI to discriminate death cells (right panels).
doi:10.1371/journal.pone.0013700.g008
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phase for further ageing. This suggests that the relationship
between S129 phosphorylation and toxicity of a-Syn is growth-
phase dependent and that it may only be relevant in post-mitotic
cells. Noteworthy, it has been reported that the phosphorylation of
a-Syn at S129 is not critical for its interaction with synphilin-1
[72]. This could explain why the increase in S129 phosphorylation
observed in our experiments upon co-expression of synphilin-1 is
less pronounced than the increase in a-Syn inclusions.
Another striking observation is that the expression of SY
WT or
SY
R621C was less toxic for exponential yeast cells than the
expression of a-Syn, although both proteins displayed much
higher capacities to form inclusions. This underscore that there is
no correlation between the level of cytotoxicity and the absolute
number of inclusions being formed in yeast cells, which is
consistent to previously published reports [10,31,32]. In fact,
studies in mammalian cell lines and transgenic mice indicated that
synphilin-1 can form deleterious aggregates as well as cytoprotec-
tive aggresomes [19,22,23]. Interestingly, these properties are
associated with distinct protein domains, i.e. the aggregation of
synphilin-1 is dependent on the coiled-coil domain and the second
ankyrin-like repeats domain, while aggresome formation requires
the first ankyrin-like repeats domain [22]. Aggresomes are larger
than aggregates and they are formed near the centrosome by
microtubule-dependent transport of aggregated proteins in
response to a failing proteasome. Their formation is usually
considered to be cytoprotective response because aggresomes can
be cleared via autophagy, thereby providing the cell an additional
mechanism to deal with misfolded and insoluble proteins. We
observed that smaller synphilin-1 inclusions transformed into one
or a few larger inclusions located near the nucleus when the cells
traversed the diauxic shift to enter stationary phase. Furthermore,
cells harboring such large inclusions failed to stain positive with
DHE and propidium iodide. These observations suggest that both
wild-type and mutant synphilin-1 are subject to aggresome
formation in yeast as well. This may explain, at least in part,
why the aggregation of synphilin-1 does not translate into an
extensive growth defect. Furthermore, the formation of synphilin-1
aggresomes may also lead to sequestration of noxious forms of a-
Syn, thereby providing an alternative to deal with this protein as
well, on condition that the overall capacity for aggresome
formation is not exceeded. Apparently, this is still the case for
combined expression of SY
R621C and a-Syn in late exponential
cells. Note, however, that the cytoprotective function of aggre-
somes has been questioned since their occurrence is often
associated with disease states where they are believed to trigger
deregulation of normal cellular homeostasis [73]. In our yeast
model it is obvious that aggresome formation did not prevent that
SY
WT and SY
R621C incited cytotoxicity during ageing, certainly
not when their expression was combined with that of a-Syn. One
may argue that aged yeast cells are more vulnerable to
heterologous expression of synphilin-1 and a-Syn because their
mechanisms to handle misfolded proteins are already operating at
maximal capacity due to elevated levels of damaged endogenous
proteins. In addition, the overwhelming aggregation of synphilin-1
and excessive aggresome build-up during growth could trigger the
deregulation of autophagic processes when these become activated
in response to nutrient starvation [74]. For instance, the
autophagic clearance of aggresomes could interfere with the
quality control and recycling of essential cellular constituents, such
as mitochondria by means of mitophagy, as these processes are all
dependent on a common core machinery [75]. Consistent with the
latter scenario is the observation that, despite its extensive
aggregation and formation of large inclusions, synphilin-1 did
not trigger additional cytotoxicity when expressed in cells lacking
the sirtuin Sir2, a protein required to maintain the autophagic flux
upon nutrient deprivation [60].
The finding that Sir2 is an essential mediator of synphilin-1
toxicity also pointed us to another process that appears to be
influenced by the presence of aggregates and aggresomes and that
is particularly relevant during mitotic growth. Indeed, a recent
study identified Sir2 as being essential for the proper CCT-
chaperonin-dependent folding of actin and the establishment of
cell polarity [61]. Sir2 thereby controls the efficient retention of
aggregates by mother cells and the clearance of aggregates from
daughter cells via an actin dependent retrograde transport.
Careful examination of wild-type cells revealed that synphilin-1
inclusions localized to actin cables and that the individual
inclusions were usually flanked by an actin patch. These
observations suggest that synphilin-1 inclusions trigger the
delocalization of the actin cytoskeleton as to allow transport of
aggregates along actin cables. Furthermore, we found that the
expression of SY
WT in wild-type cells caused hypersensitivity to
Latranculin-B, an actin-depolarizing drug. It is therefore tempting
to speculate that this actin-mediated transport of synphilin-1
inclusions permits to produce a more long-lived progeny and that
it contributes to the formation of aggresomes in mother cells.
However, these issues remain to be investigated in more detail in
future studies.
Materials and Methods
Cloning of Synhilin-1 and a-synuclein
The synphilin-1 cDNA was isolated from a hippocampal cDNA
library via PCR amplification using the primers CATGCCATG-
GAAGCCCCTGAATACC and CCGCTCGAGTTATGCTG-
CCTTATTCTTTCC that included, respectively, a NcoI and
XhoI restriction site for cloning into the pYX212 plasmid, which
allows expression from the constitutive TPI1 promoter. The
sequence for dsRed was amplified with the primers CATGC-
CATGGATGGACAACACCGAGGACG and CATGCCATG-
GCTGGGAGCCGGAGTG both including a NcoI site for in-
frame cloning into the pYX212-synphilin-1 plasmid constructed
above. The N-terminally tagged EGFP-synphilin-1 plasmid was
made using the gateway technology, where the expression cassette
was placed under control of the glyceraldehydes-3-phosphate
dyhydrogenase (TDH3) promoter. The cDNA of the clinical
synphilin-1 R621C mutant was a gift from Dr. R. Kru ¨ger (Center
of Neurology, Tu ¨bingen, Germany) and was also subcloned into
the pYX212 plasmid using the primers described above, allowing
to express the protein as native or dsRed-tagged version.
Generation of the pUG23/a-synuclein and Yep181/a-synuclein
vectors has been described previously [41]. The plasmids used to
Figure 9. Transport of synphilin-1 inclusions along actin cables. A: Fluorescence microscopy images of late exponential sir2D cells expressing
dsRed-SY
WT and a-Syn-EGFP showing that daughter cells inherit cytosolic synphilin-1 inclusions and plasma membrane associated a-Syn. B:
Fluorescence microscopy images of late exponential wild-type cells expressing dsRed-SY
WT stained with Alexa Fluor 488 phalloidin to visualize actin
patches and actin fibers and with Calcofluor to visualize the cell wall. Shown are the pictures obtained with the fluorescent proteins or dyes as well as
the corresponding merges. C: Assessment of growth of wild-type cells with or without expression of native SY
WT or SY
R621C when plated on media
supplemented with either Latranculin-B, Benomyl or the solvent DMSO.
doi:10.1371/journal.pone.0013700.g009
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[76,77].
Yeast cultures and determination of cell survival
In this study we used the wild-type BY4741 (MATa his3D leu2D
met15D ura3D) strain. The Gietz method was used for transforma-
tions [78]. All strains were grown on SC medium containing
0.17% yeast nitrogen base (Difco, Lawrence KS, USA), 0.5%
(NH4)2SO4, 30 mg/l adenine, 80 mg/l histidine, 30 mg/l of all
other amino acids (leucine and/or the pyrimidine uracil were
omitted to serve as selection marker) and 2% glucose (SCD). In
order to test growth retardation caused by native a-Syn or
synphilin-1, alone or in combination, the growth profiles of the
corresponding strains were compared to that of a control strain
transformed with the empty vectors. Overnight precultures of at
least three independent transformants were used to inoculate new
cultures in SCD medium at a starting OD600 of 0.01 in microtiter
plates, which were incubated at 30uC without shaking. The growth
profiles were then established by measuring OD600 in a DTX880
multimode detector (Beckman Coulter, California, USA) until the
stationary phase was reached. For growth assays on solid medium,
a serial dilution of exponentially growing cells was made in SCD
medium ranging from an OD600 of 1 to 0.0001. Of these dilutions,
5 ml was spotted on SCD agar plates, which were then incubated
at 30uC for at least 48 h. To determine survival upon a-synuclein
and synphilin-1 expression, cells from overnight cultures were
inoculated in tubes on SCD to OD600 0.1, and grown at 30uC and
145 rpm. At different times after inoculation, cultures were
subjected to cell counting using a CASY cell counting device
(Scha ¨rfe system). 500 cells were plated on YPD agar plates, and
colony forming units were determined after 2 days with a
Microbiology colony counter (LemnaTec GmbH, Wu ¨rselen,
Germany) and processed using SAWmicrobio version 3.1. For
chronological ageing experiments, cultures were grown in flasks
with vigorous shaking and processed as previously described
[37,79]. Notably, at least three independent transformants were
tested for the survival plating to rule out clonogenic variation of
the effects.
Cell cultures
Human H4 neuroglioma cells (HTB-148; ATCC, Manassas,
VA, USA) were maintained in OPTI-MEM (Gibco/Invitrogen
corporation, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum. H4 cells were passaged 24 hours prior to
transfection and plated in 10 cm dishes for western blot analysis.
Cells were transfected with equimolar ratios of plasmids using
Fugene6 (Roche, Mannheim, Germany) according to the
manufacturer’s instructions. To prepare primary neuronal cul-
tures, cortices from 16 days old embryos were dissected and
conserved in L15 medium (Gibco/Invitrogen corporation, Carls-
bad, CA, USA) supplemented with 30 mM glucose till dissocia-
tion. Mechanical dissociation of the mixed glial cells was
performed using flamed Pasteur pipets and the cells were plated
at a density of 200000 cells/cm
2 in poly-D-lysine and laminin-
coated plates. For dissociation, plating and maintenance, we used
Neurobasal medium supplemented with 200 mM glutamine, 2%
B27 supplement and 1% antibiotic/antimycotic agents (Gibco/
Invitrogen corporation, Carlsbad, CA, USA).
Western blot analysis
Yeast samples for western blot analysis were prepared according
to Zabrocki and co-authors [41]. For quantitative analysis, strains
were grown to mid-exponential phase (OD600 of 2.0) and an equal
amount of cells was taken for protein extraction. Proteins were
then separated by SDS-PAGE. Human H4 neuroglioma cells were
washed with cold phosphate buffered saline (PBS) 36 hours post
transfection cells, and lysed with NP-40 buffer in the presence of
protease inhibitor cocktail (Roche, Mannheim, Germany). Lysates
were cleared from debris by a 8000xg centrifugation for 15 min at
4uC and were then subjected to SDS-PAGE. After blotting, the
filters were washed three times in TBS with 0.1% Tween (TBS-T,
pH 7.4), and bands were stained using antibodies listed below,
followed by incubation with HRP labeled secondary antibodies.
After washing three times in TBS-T, the immunoblots were
developed using ECL. The primary antibodies used were specific
for Pma1 (kind gift from Dr. B. Andre ´, ULB, Belgium), synphilin-1
(Sigma Aldrich, St. Louis, MO, USA), a-synuclein (Sigma Aldrich,
St. Louis, MO, USA and BD Transduction Laboratories, San
Jose, CA, USA), phospho-serine 129 (P-S129) a-synuclein (Wako
Chemicals USA, Inc., Richmond VA, USA and Abcam, Cam-
bridge, UK) and flotillin-1 (Cell Signalling, Danvers MA, USA).
To quantify expression of wild-type and mutant synphilin-1 in the
yeast strains, the endogenous alcohol dehydrogenase Adh2 served
as internal standard.
Microscopy and determination of cell death markers
Fluorescence microscopy of yeast was performed with a Leica
DM4000B microscope. Transformants with the expression
cassettes for EGFP- or dsRed-fused a-Syn or Synphilin-1 were
inoculated in tubes on SCD to OD600 0.1 and incubated for
16 hours at 30uC as described previously [41]. The proportion of
cells with the a-synuclein and synphilin-1 inclusions within the
population was then determined by manual inspection of at least
600 cells per strain. Data from different experiments were
combined to calculate the significance of the data using a t-test.
Yeast intracellular lipid droplets were stained with the non-polar
BODIPY 505/515 fluorescent probe. The fatty acid C1-BODIPY
500/510-C12, which serves as fluorescent precursor for phospho-
lipid synthesis, was used to stain lipid particles. Both stainings were
done with the same protocol. Briefly, cells were grown on selective
medium till OD600 of 0.4 at 30uC. Then the fluorophore was
added to an end concentration of 5 mM and the cells were further
incubated for 1 h. After centrifugation, the cells were washed three
times in synthetic medium, resuspended in medium and visualized
under the microscope. For filipin staining of sterols the cells were
concentrated by a brief centrifugation and filipin (Sigma Aldrich,
St. Louis, MO, USA), dissolved in dimethyl sulfoxide, was then
added at a final concentration of 5 mg/ml. Staining with DAPI,
Calcofluor or Alexa Fluor 488 conjugated phalloidin (Molecular
Probes, Eugene, OR, USA) involved the fixation of cells with
formaldehyde as previously described [80].
Tests for apoptotic and necrotic markers (using AnnexinV/PI
co-staining) as well as ROS-accumulation using the superoxide-
driven conversion of non-fluorescent dihydroethidium (DHE) to
fluorescent ethidium were performed and quantified using flow
cytometry as described previously [37]. Significance of the data
was determined by t-test analysis.
Transfected H4 cells were washed with PBS and fixed with 4%
paraformaldehyde for 10 min at RT. After washing with PBS cells
were permeabilized in TBS containing 0.1% Triton X-100 for
20 min at RT. After blocking in 1.5% normal goat serum
containing TBS for 1 hour cells were incubated with primary
antibody for 2 hours at RT or overnight at 4uC (mouse anti-Syn-1;
BD Transduction Laboratories, San Jose, CA, USA) followed by
washing with PBS and secondary antibody incubation for 1 hour
(goat anti-rat IgG-Alexa488, 1:300; Molecular Probes, Eugene,
OR, USA). After a final wash, slides were mounted with aqueous
mounting solution (GVA; Zymed, San Francisco, CA, USA) and
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the a-synuclein inclusions within the population was then
determined by counting. All data were analyzed using a t-test.
Primary neuronal cultures (11 DIV) from embryonic mouse
cortex were analyzed by confocal microscopy. The cells were
incubated with Alexa Fluor 488 conjugated cholera toxin subunit
B (CT-B; Molecular Probes, Eugene, OR, USA), which serves a
marker for lipid rafts [45], at a concentration of 10 mg/ml in D-
PBS for 1 h on ice. Cells were washed with D-PBS and fixed in
cold 4% paraformaldehyde in 0,1 M phosphate buffer, pH 7,4, for
30 min at room temperature. Permeabilization was carried out in
0.2% Triton X-100 in phosphate-buffered saline for 10 min. After
a 30 min saturation in 2% bovine serum albumin, immunostain-
ing was carried out using goat anti-synphilin 1 (AHP 593; Serotec,
Oxford, UK). Synphilin-1 staining was detected with a donkey
anti-goat IgG (H+L) antibody coupled to Alexa Fluor 568
(Molecular Probes, Eugene, OR, USA). Cells were mounted with
the Vectashield mounting medium with DAPI (Molecular Probes,
Eugene, OR, USA). Slides were analyzed with a Zeiss LSM710
confocal laser scanning microscope. A Zeiss LSM710 confocal
laser program was used to visualize co-localization between
synphilin-1 and Alexa Fluor 488Hconjugated CT-B.
Isolation of detergent-resistant lipid raft fractions
For yeast, an amount of exponentially grown cells equivalent to
an OD600 of 20 was taken to perform the isolation of lipid raft
fractions. The exponential cells were washed once with chilled
water and lysed using a standard protocol with glass beads. Lysis
was performed in TNE buffer (50 mM Tris–HCl, pH 7.4,
150 mM NaCl and 5 mM EDTA) with addition of inhibitors
(1 mM benzamidine, 1 mM PMSF and a cocktail of protease
inhibitors (Roche, Mannheim, Germany)). Lysates were centri-
fuged at 500 g for 5 min at 4uC. 0.2% Triton-X-100 was added to
the lysates and these were then incubated on ice for 30 min.
Fractions were mixed with OptiPrep (Sigma Aldrich, St. Louis,
MO, USA) solution to reach 35% concentration (v/v), then
overlaid with 1.2 ml of 30% OptiPrep solution (v/v) and 200 mlo f
TNE. The samples were centrifuged at 259,000 g for 16 h at 4uC
in SW55Ti rotor (Beckman Coulter, Brea, CA, USA). Nine equal
fractions were taken and precipitated by adding 50% trichlor-
oacetic acid. Samples were centrifuged and protein pellets were
resuspended in 26SDS-PAGE buffer. Equal volumes of particular
fractions were analyzed by SDS-PAGE and western blotting. For
lipid raft analysis of mammalian cells, 11 DIV neuronal cultures
were washed with PBS and harvested immediately in TBS
containing 1% triton-X-100, phosphatase inhibitors (1 mM
Na3VO4, 0.1 mg/ml okadaic acid) and a protease inhibitors mix
(Roche, Mannheim, Germany) and then incubated on ice for
30 min. Lysates were centrifuged at 1,000 g and supernatants
were collected. The total protein concentrations were determined
by using the BCA protein assay kit (Pierce Biotechnology,
Rockford, IL, USA). A total amount of 1 mg of protein extracts
was used to perform the isolation of lipid raft fractions. The lysates
were mixed with a sucrose solution to reach 40% concentration
(m/v) and then overlaid with 6 ml of 35% sucrose (m/v) and
subsequently with 1.3 ml of 5% sucrose (m/v). The samples were
centrifuged at 200,000 g for 18 h at 4uC in SW60 rotor (Beckman
Coulter, Brea, CA, USA). Eight equal fractions were taken and
every fraction was precipitated by adding 100% trichloroacetic
acid. Samples were centrifuged and protein pellets were
resuspended in 26SDS-PAGE buffer. Equal volumes of particular
fractions were analyzed by SDS-PAGE and western blotting.
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